A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma.

Autor: Ingle, James N., Johnson, Patricia A., Suman, Vera J., Gerstner, James B., Mailliard, James A., Camoriano, John K., Gesme, Dean H., Loprinzi, Charles L., Hatfield, Alan K., Hartmann, Lynn C., Ingle, J N, Johnson, P A, Suman, V J, Gerstner, J B, Mailliard, J A, Camoriano, J K, Gesme, D H Jr, Loprinzi, C L, Hatfield, A K, Hartmann, L C
Zdroj: Cancer (0008543X); Jul1997, Vol. 80 Issue 2, p218-224, 7p
Databáze: Complementary Index
Externí odkaz: